메뉴 건너뛰기




Volumn 87, Issue 4, 2000, Pages 553-558

A HER2/NEU-derived peptide, a K(d)-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8+ cytotoxic T lymphocytes

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; HLA A2 ANTIGEN; TUMOR REJECTION ANTIGEN;

EID: 0033882792     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000815)87:4<553::AID-IJC15>3.0.CO;2-8     Document Type: Article
Times cited : (41)

References (39)
  • 26
    • 0031890206 scopus 로고    scopus 로고
    • Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
    • (1998) Nature (Med.) , vol.4 , pp. 321-327
    • Rosenberg, S.A.1
  • 29
    • 0028289244 scopus 로고
    • Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin 4 and down regulated by tumor necrosis factor alpha
    • (1994) J. Exp. Med. , vol.179 , pp. 1109-1118
    • Sallusto, F.1    Lanzavecchia, A.2
  • 34
    • 0031819536 scopus 로고    scopus 로고
    • The MHC class I ligand-generating system: Roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28
    • (1998) Immunol. Rev. , vol.163 , pp. 161-176
    • Tanaka, K.1    Kasahara, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.